Position in ARWR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$30,557,854
+$5,199,717 QoQ
Shares Held
374,897
-7.3% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#50
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ARWR ranks #11 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,557,854 | 374,897 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $25,358,137 | 404,436 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $23,395,504 | 352,395 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,799,652 | 371,112 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,687,952 | 359,997 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,407,772 | 345,979 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $7,150,467 | 380,344 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $7,214,007 | 372,432 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,954,923 | 383,029 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $10,642,203 | 372,105 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,864,491 | 322,369 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $9,159,096 | 340,867 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,253,631 | 343,624 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $8,775,319 | 345,485 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $14,043,129 | 346,231 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,843,539 | 328,095 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $11,130,268 | 316,111 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $13,314,196 | 289,502 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $18,746,192 | 282,748 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $17,660,198 | 282,880 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $23,349,111 | 281,926 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $19,162,064 | 288,977 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $22,837,917 | 297,640 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $12,908,828 | 299,787 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $14,393,715 | 333,265 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,956,992 | 311,331 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||